Cytochrome P-450 expression in sudden infant death syndrome

Biochemical Pharmacology

Volumn 52, Issue 3, 1996, Pages 497-504

  Treluyer, Jean Marc ^b   Cheron, Gérard ^b   Sonnier, Michelle ^b   Cresteil, Thierry ^a  

^a INSERM   (France)

^b NONE

Author keywords

CYP2C; cytochromes P 450; diazepam; epoxyeicosatrienoic acids; human liver; sudden infant death syndrome

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450 ISOENZYME; DIAZEPAM; ENZYME ANTIBODY; RNA; TOLBUTAMIDE; UNSPECIFIC MONOOXYGENASE;

ADULT; APNEA; ARTICLE; AUTOPSY; CHILD; CONTROLLED STUDY; DEMETHYLATION; DRUG METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; INFANT; LIVER MICROSOME; LUNG; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE RELAXATION; SUDDEN INFANT DEATH SYNDROME;

EID: 0004283269     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00253-5     Document Type: Article

References (48)

1. 1. Bouvier-Colle MH, Inizan J and Michel E, Postneonatal mortality, sudden infant death syndrome: factors preventing the decline of infant mortality in France from 1973 to 1985. Paediatr Perinatal Epidemiol 3: 250-261, 1989.
2. 2. Ponsonby AL, Dwyer T and Jones ME, Sudden infant death syndrome: seasonality and a biphasic model of pathogenesis. J Epidemiol Community Health 46: 33-37, 1992.
3. 3. Shannon DC and Kelly DH, SIDS and near-SIDS. N Engl J Med 306: 956-965, 1982.
4. 4. Grether JK and Schulman J, Sudden infant death syndrome and birth weight. J Pediatr 114: 561-567, 1989.
5. 5. Cheron G, Rambaud C, Rey C, Mahut B, Canioni D, Lavaud J, Rouzioux C, Hubert P, Rudler M, Brousse N and Nezelof C, Morts subites au berceau. Expérience d'un centre de référence, 1986-1991. Arch Fr Pediatr 50: 293-299, 1993.
6. 6. Lundemose JB, Smith H and Sweet C, Cytokine release from human peripheral blood leucocytes incubated with endotoxin with and without prior infection with influenza virus: relevance to the sudden infant death syndrome. Jnt J Exp Path 74: 291-297, 1993.
7. 7. Stoltenberg L, Saugstad OD and Rognum TO, Sudden infant death syndrome victims show local immunoglobulin M response in tracheal wall and immunoglobulin A response in duodenal mucosa. Pediatr Res 31: 372-375, 1992.
8. 8. Kahn A and Blum D, Phenothiazines and sudden death infant syndrome. Pediatrics 70: 75-78, 1982.
9. 9. Renton KW and Mannering GJ, Depression of hepatic cytochrome P450 monooxygenase systems with administered interferon inducing agents. Biochem Biophys Res Commun 73: 343-348, 1976.
10. 10. Stanley LA, Adams DJ, Lindsay R, Meehan RR, Liao W and Wolf CR, Potentiation and suppression of mouse liver cytochrome P450 isoforms during the acute-phase response induced by bacterial endotoxin. Eur J Biochem 174: 31-36, 1988.
11. 11. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K and Nebert DW, The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature. DNA and Cell Biol 12: 1-51, 1993.
12. 12. Cresteil T, Beaune P, Kremers P, Celier C, Guengerich FP and Leroux JP, Immunoquantification of epoxide hydrolase and cytochrome P-450 isoenzymes in fetal and adult human liver microsomes. Eur J Biochem 151: 345-350, 1985.
13. 13. Ladona MG, Spalding DJM, Ekman L, Lindström B and Rane A, Human fetal and adult liver metabolism of ethylmorphine. Relation to immunodetected cytochrome P450 PCN and interactions with important fetal corticosteroids. Biochem Pharmocol 38: 3147-3155, 1989.
14. 14. Komori M, Kanako N, Kitada M, Shimarazu K, Muroya K, Soma M, Nagashima K and Kamataki T, Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry (USA) 29: 4430-4433, 1990.
15. 15. Treluyer JM, Jacqz-Aigrain E, Alvarez F and Cresteil T, Expression of CYP2D6 in the developing human liver. Eur J Biochem 202: 583-588, 1991.
16. 16. Hakkola J, Pasanen M, Purkunen R, Saarikoski S, Pelkonen O, Mäenpää J, Rane A and Raunio H, Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 48: 59-64, 1994.
17. 17. Cresteil T, Flinois JP, Pfister A and Leroux JP, Effect of microsomal preparations and induction on cytochrome P450-dependent monoxygenases in fetal and neonatal rat liver. Biochem Pharmacol 28: 2057-2063, 1979.
18. 18. Greim H, Synthesesteigerung und abbauhemmung bei der vermchrung der mikrosomalen cytochrome P450 und b5 durch phenobarbital. Arch Pharmacol 266: 261-275, 1970.
19. 19. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ, Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
20. 20. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227: 680-685, 1970.
21. 21. Cresteil T, Marie S, Sonnier M, Kersual J and Gonzalez F, Evidence for the transient expression of P450 during the neonatal period in rat. Biochim Biophys Acta 1208: 111-117, 1994.
22. 22. LeProvost E, Cresteil T, Columelli S and Leroux JP, Immunological and enzymatic comparison of hepatic cytochrome P450 fractions from phenobarbital, 3 methylcholanthrene, β-naphtoflavone and 2,3,7,8 tetrachlorodibenzo-p-dioxin treated rats. Biochem Pharmacol 32: 1673-1682, 1983.
23. 23. Wang P, Beaune P, Kaminsky LS, Dannan GA, Kadlubar FF, Larrey D and Guengerich FP, Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry (USA) 22: 5375-5383, 1983.
24. 24. Kiffel L, Celier C and Leroux JP, Purification and characterization of P450 isozyme isolated from liver of rats pretreated-with clofibrate. Biochem Biophys Res Commun 156: 282-289, 1988.
25. 25. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T and Mayer RT, Ethoxy-, pentoxy-and benzyloxphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P450. Biochem Pharmacol 34: 3337-3345, 1985.
26. 26. Peter R, Bocker R, Beaune P, Iwasaki M, Guengerich FP and Yang CS, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem Res Toxicol 3: 566-573, 1990.
27. 27. Reilly PEB, Thompson DA, Mason SR and Hooper WD, Cytochrome P450IIIA enzymes in rat liver microsomes. Involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam. Mol Pharmacol 37: 767-774, 1990.
28. 28. Knodell RG, Hall SD, Wilkinson GR and Guengerich FP, Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P450 involved in the methyl hydroxylation and relationship to in vivo disposition. J Pharmacol Exp Ther 241: 1112-1119, 1987.
29. 29. Moroy T, Etiemble J, Trepo C, Thiollais P and Buendia MA, Transcription of woodchuck hepatitis virus in the chronically infected liver. EMBO J 4: 1507-1514, 1985.
30. 30. Cresteil T, Jaiswal AK and Eisen HJ, Transcriptional control of human cytochrome P1-450 gene expression by 2,3,7,8 tetrachlorodibenzo-p-dioxin in human tissue culture cell lines. Arch Biochem Biophys 253: 233-240, 1987.
31. 31. Hamada H, Petrino MG and Kakunaga T, Molecular structure and evolutionary origin of human cardiac muscle actin gene. Proc Natl Acad Sci (USA) 79: 5901-5905, 1982.
32. 32. Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS and Guengerich FP, Characterization of cDNAs, mRNAs and proteins related to human liver microsomal cytochrome P450 (S)-mephenytoin 4′-hydroxylase. Biochemistry (USA) 27: 6929-6940, 1988.
33. 33. Furuya H, Meyer UA, Gelboin HV and Gonzalez FJ, Polymerase chain reaction-directed identification, cloning and quantification of human CYP2C18 mRN A. Mol Pharmacol 40: 375-382, 1991.
34. 34. Romkes M, Faletto MB, Blaisdell JA, Raucy JL and Goldstein JA, Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry (USA) 30: 3247-3255, 1991.
35. 35. Goldstein JA, Faletto MB, Romkes-Sparks M, Sullivan T, Kitareewan S, Raucy JL, Lasker JM and Ghanayem BI, Evidence that CYP2C19 is the major S-mephenytoin 4′-hydroxylase in humans. Biochemistry (USA) 33: 1743-1752, 1994.
36. 36. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP, Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270: 414-423, 1994.
37. 37. Yamazaki T, Qing-Hua L, Yamazoe Y, Ueda M, Tsuziki T and Kato R, Lack of low Km diazepam N demethylase in livers of poor metabolizers for S-mephenytoin 4′-hydroxylation. Pharmacogenetics 4: 323-331, 1994.
38. 38. Yasumori T, Nagata K, Yang SK, Chen LS, Murayama N, Yamazoe Y and Kato R, Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics 3: 291-301, 1993.
39. 39. Relling MV, Aoyama T, Gonzalez FJ and Meyer UA, Tolbutamide and mephenytoin hydroxylation by human cytochrotne P450s in the CYP2C subfamily. J Pharmacol Exp Ther 252: 442-447, 1990.
40. 40. Howatson AG, Viral infection and a interferon in SIDS. J Clin Pathol 45: 25-28, 1992.
41. 41. Helweg-Larsen K and Garde E, Sudden natural death in children. A review of forensic autopsy protocols in cases of sudden death between the ages of one and five years, 1982-1991, with a special view to sudden unexplained death. Acta Paediatr 82: 975-978, 1993.
42. 42. Howat WJ, Moore IE, Judd M and Roche WR, Pulmonary immunopathology of sudden infant death syndrome. Lancet 343: 1390-1392, 1994.
43. 43. Daikh BE, Lasker JM, Raucy JL and Koop DR, Regio-and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. J Pharmacol Exp Ther 271: 1427-1433, 1994.
44. 44. Rosolowsky M and Campbell WB, Role of PGI2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol 264: H327-335, 1993.
45. 45. Pinto A, Abraham NG and Mullane KM, Cytochrome P450-dependent monoxygenase activity and endothelial-dependent relaxations induced by arachidonic acid. J Pharmacol Exp Ther 236: 445-451, 1986.
46. 46. Bysani GK, Kennedy TP, Ky N, Rao NV, Blaze CA and Hoidel JR, Role of cytochrome P450 in reperfusion injury of the rabbit lung. J Clin Invest 86: 1434-1441, 1990.
47. 47. Moffat MP, Ward CA, Bend JR, Mock T, Farhangkhoee P and Karmazyn M, Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes. Am J Physiol 264: H1154-1160, 1993.
48. 48. Lewis AB, Freed MD, Heymann MA, Roehl SL and Kensey RC, Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64: 893-898, 1981.